AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 68 filers reported holding AVIDITY BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,193,079 | +1.5% | 970,702 | +76.5% | 0.00% | 0.0% |
| Q2 2023 | $6,099,578 | -28.1% | 550,007 | -0.5% | 0.00% | 0.0% |
| Q1 2023 | $8,488,750 | +306132.0% | 552,984 | +342.7% | 0.00% | – |
| Q4 2022 | $2,772 | -99.8% | 124,918 | +12.4% | 0.00% | – |
| Q3 2022 | $1,814,000 | -1.4% | 111,121 | -12.2% | 0.00% | – |
| Q2 2022 | $1,840,000 | -1.5% | 126,582 | +25.2% | 0.00% | – |
| Q1 2022 | $1,868,000 | -29.4% | 101,115 | -9.2% | 0.00% | – |
| Q4 2021 | $2,647,000 | +296.3% | 111,371 | +310.9% | 0.00% | – |
| Q3 2021 | $668,000 | +56.4% | 27,105 | +56.9% | 0.00% | – |
| Q2 2021 | $427,000 | +29.4% | 17,278 | +14.1% | 0.00% | – |
| Q1 2021 | $330,000 | +71.9% | 15,139 | +101.6% | 0.00% | – |
| Q4 2020 | $192,000 | +6.7% | 7,509 | +20.4% | 0.00% | – |
| Q3 2020 | $180,000 | – | 6,235 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,571,160 | $40,096,000 | 20.10% |
| Aaron Wealth Advisors LLC | 524,239 | $13,378,000 | 4.90% |
| Octagon Capital Advisors LP | 430,041 | $10,975,000 | 3.80% |
| EcoR1 Capital, LLC | 2,103,950 | $53,693,000 | 2.89% |
| RTW INVESTMENTS, LP | 3,995,000 | $101,952,000 | 1.71% |
| ACUTA CAPITAL PARTNERS, LLC | 246,200 | $6,283,000 | 1.71% |
| Cormorant Asset Management, LP | 2,464,547 | $62,895,000 | 1.50% |
| Logos Global Management LP | 671,454 | $17,136,000 | 1.47% |
| Boxer Capital, LLC | 1,121,327 | $28,616,000 | 0.92% |
| HighVista Strategies LLC | 26,665 | $680,000 | 0.43% |